• Citer

Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer

par Lei, Ming;Overman, Michael James;Yao, Jin;André, Thierry;Lonardi, Sara;Lenz, Heinz-Josef;Aglietta, Massimo;Gelsomino, Fabio;McDermott, Ray;Wong, Ka Yeung Mark;Morse, Michael M.A.;Van Cutsem, Eric;Hendlisz, Alain ;Cardin, Dana Backlund D.;Neyns, Bart;Hill, Andrew;Krishnamurthy, Anuradha;Chen, Franklin;Kochuparambil, Samith;Jenq, Robert R.R.;Abdullaev, Sandzhar;He, Beilei;Novosiadly, Ruslan;Kopetz, Scott
Référence Nature communications, 16, 1, 8868
Publication Publié, 2025-12

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer
Auteur:	Lei, Ming; Overman, Michael James; Yao, Jin; André, Thierry; Lonardi, Sara; Lenz, Heinz-Josef; Aglietta, Massimo; Gelsomino, Fabio; McDermott, Ray; Wong, Ka Yeung Mark; Morse, Michael M.A.; Van Cutsem, Eric; Hendlisz, Alain; Cardin, Dana Backlund D.; Neyns, Bart; Hill, Andrew; Krishnamurthy, Anuradha; Chen, Franklin; Kochuparambil, Samith; Jenq, Robert R.R.; Abdullaev, Sandzhar; He, Beilei; Novosiadly, Ruslan; Kopetz, Scott
Informations sur la publication:	Nature communications, 16, 1, 8868
Statut de publication:	Publié, 2025-12
Sujet CREF:	Chimie
	Physique
	Astronomie
	Technologie de l'environnement, contrôle de la pollution
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:2041-1723
	info:doi/10.1038/s41467-025-63960-8
	info:scp/105017951553
	info:pmid/41053075